Molecular formula: | C19H17F2N3O5 |
Average mass: | 405.357 |
Monoisotopic mass: | 405.113627 |
ChemSpider ID: | 30829503 |
2 of 2 defined stereocentres
Wikipedia
(3S,11aR)-N-(2,4-Difluorbenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazin-8-carboxamid
[German]
[ACD/IUPAC Name](3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
[ACD/IUPAC Name](3S,11aR)-N-(2,4-Difluorobenzyl)-6-hydroxy-3-méthyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
[French]
[ACD/IUPAC Name]1051375-10-0
[RN]cabotegravir
[Spanish]
[INN]cabotégravir
[French]
[INN]cabotegravirum
[Latin]
[INN]GSK1265744A
HMH0132Z1Q
[UNII]Oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide, N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-, (3S,11aR)-
[ACD/Index Name]каботегравир
[Russian]
[INN]كابوتيغرافير
[Arabic]
[INN]卡替拉韦
[Chinese]
[INN](3s,11ar)-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxylic acid
(3S,11aR)-N-(2,4-difluorobenzyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
(3S,11aR)-N-[(2,4-Difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide
3,5-dimethyl-1-pyrazolecarboximidamide
3,5-Dimethylpyrazole-1-Carboxamidine
CAB
cabotégravir
cabotegravir ,gsk744,
cabotegravir(gsk1265744a,gsk-744)
cabotegravir(gsk744,gsk1265744)
cabotegravir; cabotegravirum
cabotegravirum
GSK 744;GSK-744
GSK-1265744;S/GSK1265744
GSK-1265744A
GSK744 (S/GSK1265744)
GSK744 LA
GSK744 LAP
MFCD25976748
[MDL number]S/GSK1265744
каботегравир
كابوتيغرافير
卡替拉韦